Integrated Computational Approaches for Drug Design Targeting Cruzipain

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Parasitology

Background:

• Chagas disease treatment requires safer and more effective drugs.
• Cruzipain, a cysteine protease from Trypanosoma cruzi, is a key target for drug development.
• Existing medications necessitate the development of novel cruzipain inhibitors.

Purpose of the Study:

• To identify novel cruzipain inhibitors using computational approaches.
• To develop and validate predictive models for drug discovery.
• To screen large compound libraries for potential Chagas disease therapeutics.

Main Methods:

• Utilized 3D-QSAR and pharmacophore modeling on 36 known inhibitors.
• Developed and trained a deep learning model on 204 active compounds.
• Screened the Drug Bank database (8533 molecules) using predictive models.
• Performed molecular docking, induced-fit docking, and molecular dynamics simulations.

Main Results:

• Pharmacophore and deep learning models identified 1012 and 340 drug-like molecules, respectively.
• Rigorous virtual screening and docking identified potent inhibitor candidates.
• Four novel compounds demonstrated strong binding interactions and inhibitory potential against cruzipain.

Conclusions:

• The study successfully identified four novel cruzipain inhibitors.
• Computational methods are effective in discovering new drug leads for Chagas disease.
• These novel inhibitors show promise for the development of improved Chagas disease treatments.